The shares of aerospace giant Boeing (BA.US) are gaining nearly 3% before the opening of today's cash session on Wall Street. The reason for the gains is the Q1 earnings report, which performed better than investors had feared. The technical problems seen so far with the 737 Max aircraft are being addressed by the company, which is complying with FAA audit recommendations.
The company is slowing down business, but it is doing so intentionally. As reported by the company's CEO, the priority now is to produce aircraft in smaller numbers (38 Maxes per month), but to ensure the highest possible safety and control standards.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appSelected company results:
- Revenue $16.57 billion, ($16.25 billion expected)
- Adjusted EPS loss of $1.13 (expected loss of $1.72)
- Commercial aircraft revenue $4.65 billion, (expected $5.45 billion)
- Defense, space and security revenue $6.95 billion, (expected $6.38 billion)
- Global services revenue $5.05 billion, (expected $4.98 billion)
- Negative free cash flow $3.93 billion, (expected negative $4.4 billion)
- Negative cash flow from operating activities $3.36 billion, (negative $2.77 billion expected)
- Basic loss per share $1.13
- Backlog $529 billion
- Defense, space security operating profit $151 million, (expected $62.7 million)
- Global services operating profit $916 million, (expected $824.7 million)
Other key information:
- 737 program slowed production below 38 units per month
- Backlog at end of quarter rose to $529 billion
- Results reflect lower deliveries of 737 aircraft and the grounding of the 737 max 9 version
- Boeing assured that it is making intensive efforts to strengthen the quality and safety of its aircraft (a reference to the numerous defects and failures we have witnessed since the beginning of the year)
- The commercial flight division is implementing the FAA agency's audit turnaround procedures against the production of 737 aircraft
The company's current valuation before the opening of the cash session on Wall Street. Source: xStation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.